Castle Biosciences (CSTL) Change in Inventory (2018 - 2026)

Castle Biosciences has reported Change in Inventory for 9 years, with the latest figure at $119000.0 in Q2 2026.

• Quarterly Change in Inventory fell 92.16% year-over-year to $119000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.2 million (up 533.71% YoY) and the FY2025 annual result came in at $2.1 million, up 1009.84% from the prior year.
• Change in Inventory slipped to $119000.0 in Q2 2026 per CSTL's latest filing, from $207000.0 in the prior quarter.
• Over five years, Change in Inventory peaked at $2.2 million in Q4 2023 and troughed at -$1.4 million in Q3 2024.
• A 5-year average of $461277.8 and a median of $348500.0 in 2022 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2023 and 2025: Change in Inventory soared 1120.79% in 2023, then plunged 333.0% in 2025.
• Over 5 years, Change in Inventory stood at $178000.0 in 2022, then jumped by 1120.79% to $2.2 million in 2023, then declined by 28.07% to $1.6 million in 2024, then gained by 2.62% to $1.6 million in 2025, then sank by 92.58% to $119000.0 in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered $119000.0, $207000.0, and $1.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.